Streptavidin pull down followed by mass spectrometry of excised proteins in the 30–40 kDa range identified prohibitin-2 (PHB2) as a binding partner of SLAMF1 and SLAMF7 receptors in CLL. The gene discussed is PHB2; the disease is B-cell chronic lymphocytic leukemia.